Drugs / MTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06985498 Background | Jun 2025 → Jun 2029 | acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | “Prior to autologous stem cell transplantation (Auto-HSCT), patients receive high-dose MTX for CNS prophylaxis.” NCT06985498 ↗ |